Systemic immune cell activation in a subgroup of patients with idiopathic pulmonary fibrosis

Respiration

Volumn 70, Issue 3, 2003, Pages 262-269

  Homolka, Jiri ^c   Ziegenhagen, Manfred W ^a   Gaede, Karoline I ^b   Entzian, Peter ^b   Zissel, Gernot ^a   Müller Quernheim, Joachim ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Bronchoalveolar lavage; Idiopathic pulmonary fibrosis; Interleukin 2; Tumor necrosis factor

Indexed keywords

BIOCHEMICAL MARKER; CORTICOSTEROID; CYTOKINE; INTERLEUKIN 2; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; IMMUNOCOMPETENT CELL; LUNG FIBROSIS; LUNG LAVAGE; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE;

BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PULMONARY FIBROSIS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042573735     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072007     Document Type: Article

References (42)

1. King TE Jr: Idiopathic pulmonary fibrosis; in Schwarz MI, King TE Jr (eds): Interstitial Lung Disease, ed 3. Hamilton-London, Decker, 1998, pp 597-644.
2. Katzenstein ALA, Meyers JL: Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-1315.
3. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, Offord KP: Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;157:199-203.
4. Cottin V, Donsbeck AV, Revel D, Loire R, Cordier JF: Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998;158:1286-1293.
5. Aston C, Jagirdar J, Lee TC, Hur T, Hintz RL, Rom WN: Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995;151:1597-1603.
6. Martinet Y, Rom WM, Grotendorst GR, Martin GR, Crystal RG: Exaggerated spontaneous release of platelet derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med 1987;317:202-209.
7. Lynch JP, Standifort TJ, Rolfe MW, Kunkel SL, Strieter RM: Neutrophilic alveolitis in idiopathic pulmonary fibrosis - The role of interleukin-8. Am Rev Respir Dis 1992;145:1433-1439.
8. Southcott AM, Jones KP, Li D, Majumdar S, Cambrey AD, Pantelidis P, Black CM, Laurent GJ, Davies BH, Jeffery PK, et al: Interleukin-8: Differential expression in lone fibrosing alveolitis and systemic sclerosis. Am J Respir Crit Care Med 1995;151:1604-1612.
9. Majumdar S, Li D, Ansari T, Pantelidis P, Black CM, Gizycki M, du Bois RM, Jeffery PK: Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: A quantitative study of open lung biopsies. Eur Respir J 1999;14:251-257.
10. Haslam PL, Thompson B, Mohammed I, Townsend PJ, Hodson ME, Holborow EJ, Turner-Warwick M: Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol 1979;37:381-390.
11. Müller-Quernheim J, Saltini C, Sondermeyer P, Crystal RG: Compartmentalized activation of the interleukin-2 gene by lung T-lymphocytes in active pulmonary sarcoidosis. J Immunol 1986;137:3475-3483.
12. Müller-Quernheim J, Pfeifer S, Männel D, Strausz J, Ferlinz R: Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 1992;145:187-192.
13. Cathcar, MK, Emdur LI, Ahtiala-Stewart K, Ahmad M: Excessive helper T-cell function in patients with idiopathic pulmonary fibrosis: Correlation with disease activity. Clin Immunol Immunopathol, 1987;43:382-394.
14. Emura M, Nagai S, Takeuchi M, Kitaichi M, Izumi T: In vitro production of B cell growth factor and B cell differentiation factor by peripheral blood mononuclear cells and bronchoalveolar lavage T lymphocytes from patients with idiopathic pulmonary fibrosis. Clin Exp Immunol 1990;82:133-139.
15. American Thoracic Society: Idiopathic pulmonary fibrosis: Diagnosis and treatment. International Consensus Statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161(2 Pt 1): 646-664.
16. Ziegenhagen MW, Schrum S, Zissel G, Zipfel PF, Schlaak M, Müller-Quernheim J: Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. J Investig Med 1998;46:223-231.
17. Costabel U, Bross KJ, Matthys H:, The immunoperoxidase slide assay: A new method for demonstration of surface antigens on bronchoalveolar lavage cells. Bull Eur Physiopathol Respir 1985;21:381-387.
18. Homolka J, Müller-Quernheim J: Increased interleukin-6 production by bronchoalveolar lavage cells in patients with active sarcoidosis. Lung 1993;171:173-183.
19. Behr J, Adelmann-Grill BC, Krombach F, Beinert T, Schwaiblmair M, Fruhmann G: Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis. Thorax 1993;48:736-742.
20. Agostini C, Siviero M, Semenzato G: Immune effector cells in idiopathic pulmonary fibrosis. Curr Opin Pulm Med 1997;3:348-355.
21. Behr J, Maier K, Degenkolb B, Krombach F, Vogelmeier C: Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 1997;156:1897-1901.
22. Michaelson JE, Aguayo SM, Roman J: Idiopathic pulmonary fibrosis: A practical approach for diagnosis and management. Chest 2000;118:788-794.
23. Raghu G, Depaso WJ, Cain K, et al: Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: A prospective, double-blind randomized, placebo-controlled clinical trial. Am Rev Respir Dis 1991;144:291-296.
24. Schwartz DA, Helmers RA, Galvin JR, Van Fossen DS, Frees KL, Dayton CS, Burmeister LF, Hunninghake GW: Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994;149(2 Pt 1):450-454.
25. Franchimont D, Martens H, Hagelstein MT, Louis E, Dewe W, Chrousos GP, Belaiche J, Geenen V: Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: Potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 1999;84: 2834-2839.
26. Whyte M, Hubbard R, Meliconi R, Whidborne M, Eaton V, Bingle C, Timms J, Duff G, Fac-chini A, Pacilli A, Fabbri M, Hall I, Britton J, Johnston I, Di Giovine F: Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med 2000;162(2 Pt 1): 755-758.
27. Selman M, King TE, Pardo A: Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134: 136-151.
28. Baughman RP, Lower EE: Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:70-74.
29. Yee AM, Pochapin MB: Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 2001;135:27-31.
30. Ziegenhagen MW, Rothe ME, Zissel G, Müller-Quernheim J: Exaggerated TNFα release of alveolar macrophages in corticosteroid resistant sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:185-190.
31. Saito M, Chihara J, Mouri T, Kurachi D, Yamamoto T, Nakajima S: Elevated local production of neopterin from alveolar macrophages in patients with internal lung diseases. Gen Pharmacol 1996;27:483-486.
32. Tsutsumi T, Nagai S, Imai K, Setoyama Y, Uchiyama T, Izumi T: Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis. Sarcoidosis 1994;11:102-109.
33. Meliconi R, Lalli E, Borzi RM, Sturani C, Galavotti V, Gunella G, Miniero R, Facchini A, Gasbarrini G: Idiopathic pulmonary fibrosis: Can cell mediated immunity markers predict clinical outcome? Thorax 1990;45:536-540.
34. Nassonov E, Samsonov M, Beketova T, Se-menkova L, Wachter LFD: Serum neopterin concentrations in Wegener's granulomatosis correlate with vasculitis activity. Clin Exp Rheumatol 1995;13:353-356.
35. Kravis TC, Ahmed A, Brown TE, Fulmer JD, Crystal RG: Pathogenic mechanisms in pulmonary fibrosis: Collagen-induced migration inhibition factor production and cytotoxicity mediated by lymphocytes. J Clin Invest 1976;58: 1223-1232.
36. Haslam PL, Allan F, Watling AF, Barrett C, Morris L, Turner-Warwick M: Impaired antibody-dependent cell-mediated cytotoxicity in cryptogenic fibrosing alveolitis (synonym: Idiopathic pulmonary fibrosis). Clin Exp Immunol 1982;49:59-66.
37. Kiemle-Kallee J, Kreipe H, Radzun HJ, Parwaresch MR, Auerswald U, Magnussen H, Barth J: Alveolar macrophages in idiopathic pulmonary fibrosis display a more monocyte-like immunophenotype and an increased release of free oxygen radicals. Eur Respir J 1991;4:400-406.
38. Strausz J, Müller-Quernheim J, Steppling H, Ferlinz R: Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1990;141:124-128.
39. Hoogsteden HC, van Hal PT, Wijkhuijs JM, Hop W, Hilvering C: Expression of the CD11/CD18 cell surface adhesion glycoprotein family and interstitial lung disease. Lung 1992;170: 221-233.
40. Gruber R, Pforte A, Beer B, Rietmüller G: Determination of gamma/delta and other T-lymphocyte subsets in bronchoalveolar lavage fluid and peripheral blood from patients with sarcoidosis and idiopathic fibrosis of the lung. APMIS 1996;104:199-205.
41. Aotsuka S, Nakamura K, Nakano T, Kawa-kami M, Goto M, Okawa-Takatsuji M, Kinoshita M, Yokohari R: Production of intracellular and extracellular interleukin-1 alpha and interleukin-1 beta by peripheral blood monocytes from patients with connective tissue diseases. Ann Rheum Dis 1991;50:27-31.
42. Crestani B, Seta N, De Bandt M, Soler P, Rolland C, Dehoux M, Boutten A, Dombret MC, Palazzo E, Kahn MF, et al: Interleukin 6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvement. Am J Respir Crit Care Med 1994;149:1260-1265.